Journal
JOURNAL OF IMMUNOLOGY
Volume 186, Issue 12, Pages 7025-7038Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.0900643
Keywords
-
Categories
Funding
- Biomedical Laboratory Research and Development Service of the Veterans Affairs Office of Research and Development
Ask authors/readers for more resources
Comparative cross-species genomic analysis has served as a powerful tool to discover novel noncoding regulatory regions that influence gene expression in several cytokine loci. In this study, we have identified several evolutionarily conserved regions (ECRs) that are shared between human, rhesus monkey, dog, and horse and that are upstream of the promoter regions that have been previously shown to play a role in regulating CCL2 gene expression. Of these, an ECR that was similar to 16.5 kb (-16.5 ECR) upstream of its coding sequence contained a highly conserved NF-kappa B site. The region encompassing the -16.5 ECR conferred TNF-alpha responsiveness to homologous and heterologous promoters. In vivo footprinting demonstrated that specific nucleotide residues in the -16.5 ECR were protected or became hypersensitive after TNF-alpha treatment. The footprinted regions were found to bind NF-kappa B subunits in vitro and in vivo. Mutation/deletion of the conserved NF-kappa B binding site in the -16.5 ECR led to loss of TNF-alpha responsiveness. After TNF-alpha stimulation, the -16.5 ECR showed increased sensitivity to nuclease digestion and loss of histone signatures that are characteristic of a repressive chromatin. Chromosome conformation capture assays indicated that -16.5 ECR physically interacts with the CCL2 proximal promoter after TNF-alpha stimulation. Taken together, these results suggest that the -16.5 ECR may play a critical role in the regulation of CCL2. The Journal of Immunology, 2011, 186: 7025-7038.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available